Sarcoma, Soft Tissue: Clinical Trials

1 trial for Sarcoma, Soft Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Suspended 1

Follow Sarcoma, Soft Tissue: new trials by email Literature Review of Sarcoma, Soft Tissue trials Research Report on Sarcoma, Soft Tissue

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Pegamotecan - Sarcoma, Soft Tissue
Phase 2SuspendedEnzon Pharmaceuticals, Inc.2003-08-012012-09-06

Narrower conditions

Neoplasm Metastasis (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

pegamotecan (1)

Sponsors

Enzon Pharmaceuticals, Inc. (1)

Countries

United States (1)